1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARγ2)

[1]  L. Mosekilde,et al.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis , 2004, Biogerontology.

[2]  G. Duque.  Will reducing adopogenesis in bone increase bone mass?: PPARgamma2 as a key target in the treatment of age-related bone loss. , 2003, Drug news & perspectives.

[3]  T. Shinki,et al.  Vitamin D and bone , 2003, Journal of cellular biochemistry.

[4]  M. Macoritto,et al.  Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. , 2002, Biochemical and biophysical research communications.

[5]  J. Kirkland,et al.  Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.

[6]  Sharmila Majumdar,et al.  Changes in Bone Structure and Mass With Advancing Age in the Male C57BL/6J Mouse , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Lehmann,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Divergent Effects of Selective Peroxisome Proliferator- Activated Receptor-�2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2022 .

[8]  G. Duque,et al.  Age-Related Bone Loss: Old Bone, New Facts , 2002, Gerontology.

[9]  I. Morita,et al.  Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.

[10]  G. Duque.  Anabolic Agents to Treat Osteoporosis in Older People: Is There Still Place for Fluoride? , 2001, Journal of the American Geriatrics Society.

[11]  G. Spiteller.  Lipid peroxidation in aging and age-dependent diseases , 2001, Experimental Gerontology.

[12]  L. Binderup,et al.  The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. , 2000, Cancer research.

[13]  Qianben Wang,et al.  Specific Structural Motifs Determine TRAP220 Interactions with Nuclear Hormone Receptors , 2000, Molecular and Cellular Biology.

[14]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[15]  J. Wit,et al.  The Role of Estrogen in the Control of Rat Osteocyte Apoptosis , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  J. Gimble,et al.  1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. , 1998, Endocrinology.

[17]  T. Kawada,et al.  Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells. , 1998, Life sciences.

[18]  J. Gimble,et al.  CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.

[19]  A. Parfitt,et al.  Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  D. Dobson,et al.  Preadipocyte Function and Aging: Links Between Age‐Related Changes in Cell Dynamics and Altered Fat Tissue Function , 1997, Journal of the American Geriatrics Society.

[21]  M. Hosokawa,et al.  Senescence-accelerated mouse (SAM): A novel murine model of senescence , 1997, Experimental Gerontology.

[22]  S. Moore,et al.  Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. , 1990, Radiology.